33.67 USD
▼-0.38-1.12%
盘后 33.52 -0.44%
2026-09-15
市值
$2.29B
市盈率
—
EPS
-5.89
股息率
—
52 周区间
22.72 – 56.05
成交量
10.49M
Beta
0.95
目标价
77.36
52W 低 22.7252W 高 56.05
价格走势
公司简介
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a ...